NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 01 02:41PM ET
146.85
Dollar change
+4.40
Percentage change
3.09
%
IndexS&P 500 P/E14.54 EPS (ttm)10.10 Insider Own4.87% Shs Outstand77.28M Perf Week4.19%
Market Cap11.09B Forward P/E11.59 EPS next Y12.67 Insider Trans-38.47% Shs Float71.82M Perf Month7.77%
Enterprise Value24.74B PEG0.97 EPS next Q2.78 Inst Own93.63% Short Float8.64% Perf Quarter-4.00%
Income859.61M P/S0.85 EPS this Y10.91% Inst Trans-3.78% Short Ratio7.30 Perf Half Y-5.59%
Sales12.97B P/B- EPS next Y18.01% ROA4.98% Short Interest6.21M Perf YTD-1.81%
Book/sh-3.46 P/C18.55 EPS next 5Y14.97% ROE260.92% 52W High179.60 -18.24% Perf Year3.82%
Cash/sh7.92 P/FCF6.28 EPS past 3/5Y6.43% 15.27% ROIC7.50% 52W Low131.76 11.45% Perf 3Y89.48%
Dividend Est.1.67 (1.13%) EV/EBITDA9.30 Sales past 3/5Y3.32% 2.39% Gross Margin26.96% Volatility2.35% 2.07% Perf 5Y90.27%
Dividend TTM- EV/Sales1.91 EPS Y/Y TTM14.28% Oper. Margin15.01% ATR (14)3.22 Perf 10Y80.03%
Dividend Ex-Date- Quick Ratio1.20 Sales Y/Y TTM5.11% Profit Margin6.63% RSI (14)67.98 Recom2.83
Dividend Gr. 3/5Y- - Current Ratio1.25 EPS Q/Q-24.26% SMA205.89% Beta1.11 Target Price162.29
Payout0.00% Debt/Eq- Sales Q/Q4.98% SMA505.04% Rel Volume0.88 Prev Close142.45
Employees76000 LT Debt/Eq- EarningsMay 12 AMC SMA200-3.73% Avg Volume849.84K Price146.85
IPOOct 31, 1995 Option/ShortYes / Yes EPS/Sales Surpr.2.47% 0.52% Trades Volume603,114 Change3.09%
Date Action Analyst Rating Change Price Target Change
Mar-06-24Initiated Barclays Equal Weight $133
Aug-07-23Upgrade UBS Neutral → Buy $100 → $142
Nov-01-22Downgrade Deutsche Bank Buy → Hold $97 → $72
Oct-31-22Downgrade UBS Buy → Neutral $117 → $74
Aug-19-22Resumed UBS Buy $106 → $117
Jun-21-22Reiterated BofA Securities Underperform $110 → $90
Sep-10-21Initiated Cowen Market Perform $145
Aug-12-21Downgrade Barclays Overweight → Equal Weight $135 → $146
Mar-26-21Downgrade BofA Securities Neutral → Underperform $127 → $118
Jan-05-21Downgrade BofA Securities Buy → Neutral $127
Jun-24-25 08:19AM
03:08AM
Jun-23-25 04:26PM
Jun-19-25 06:01AM
05:57AM
08:56AM Loading…
Jun-17-25 08:56AM
Jun-16-25 06:00PM
09:40AM
Jun-11-25 11:34PM
11:30AM
Jun-04-25 10:00AM
May-30-25 02:35PM
09:40AM
May-20-25 04:42PM
09:05AM
08:51AM Loading…
08:51AM
May-19-25 10:42AM
May-18-25 02:56AM
May-17-25 09:39PM
May-15-25 07:22PM
09:45AM
May-14-25 09:40AM
07:53AM
May-13-25 12:15PM
08:44AM
03:10AM
May-12-25 07:15PM
05:15PM
04:14PM
04:13PM
04:05PM Loading…
04:05PM
May-09-25 12:39AM
May-08-25 05:45PM
11:54AM
May-07-25 06:00PM
01:54PM
07:10AM
May-05-25 05:35PM
May-02-25 08:30AM
May-01-25 06:00PM
Apr-30-25 11:00AM
Apr-28-25 07:13PM
Apr-22-25 06:00PM
Apr-19-25 07:40AM
04:30AM
Apr-18-25 06:13PM
09:41AM
Apr-17-25 06:15PM
Apr-16-25 02:41PM
Apr-15-25 06:16AM
Apr-14-25 05:08PM
12:52PM
11:16AM
07:35AM
07:33AM
Apr-12-25 04:35AM
Apr-11-25 06:21AM
Apr-10-25 06:00PM
01:18PM
05:14AM
Apr-09-25 12:31PM
Apr-03-25 06:00PM
Apr-01-25 06:15PM
Mar-31-25 06:08AM
Mar-28-25 11:30AM
Mar-26-25 06:00PM
11:59AM
Mar-25-25 06:15PM
12:38PM
10:58AM
Mar-19-25 06:00PM
Mar-14-25 12:11PM
Mar-13-25 06:00PM
05:01AM
Mar-10-25 09:35AM
05:05AM
Mar-06-25 10:00AM
Mar-05-25 05:01PM
Mar-04-25 08:15AM
Mar-01-25 06:43AM
Feb-28-25 01:30PM
Feb-27-25 09:00AM
Feb-20-25 01:28PM
10:37AM
Feb-19-25 08:05PM
Feb-17-25 08:25AM
Feb-15-25 12:21PM
Feb-14-25 05:25PM
02:23PM
12:31PM
09:58AM
08:44AM
07:43AM
02:21AM
Feb-13-25 10:00PM
08:12PM
05:20PM
05:18PM
04:22PM
04:05PM
DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BERKSHIRE HATHAWAY INC10% OwnerMay 27 '25Sale139.45103,27414,401,48333,796,541May 27 09:34 PM
BERKSHIRE HATHAWAY INC10% OwnerMay 23 '25Sale137.8164,0668,828,93333,899,815May 27 09:34 PM
BERKSHIRE HATHAWAY INC10% OwnerMay 22 '25Sale138.9832,6604,538,98333,963,881May 27 09:34 PM
BERKSHIRE HATHAWAY INC10% OwnerMay 08 '25Sale147.111,145,938168,576,64733,996,541May 12 04:05 PM
HEARTY JAMES OChief Compliance OfficerMar 03 '25Option Exercise75.954,609350,05428,669Mar 14 07:55 PM
BERKSHIRE HATHAWAY INC10% OwnerFeb 14 '25Sale154.94500,00077,471,99635,392,479Feb 19 07:47 PM
BERKSHIRE HATHAWAY INC10% OwnerFeb 19 '25Sale154.09129,93820,022,51735,142,479Feb 19 07:47 PM
BERKSHIRE HATHAWAY INC10% OwnerFeb 18 '25Sale154.60120,06218,561,10335,272,417Feb 19 07:47 PM
BERKSHIRE HATHAWAY INC10% OwnerFeb 11 '25Sale156.01203,09131,684,43035,892,479Feb 13 07:50 PM
Waters Kathleen AlyceChief Legal & Pub. Affairs OffNov 27 '24Option Exercise108.938,078879,93797,706Nov 27 09:47 PM
Michael StaffieriOfficerNov 27 '24Proposed Sale167.097,9021,320,345Nov 27 03:29 PM
Michael StaffieriOfficerNov 18 '24Proposed Sale157.427,7861,225,664Nov 18 04:27 PM
Michael StaffieriOfficerNov 14 '24Proposed Sale155.947,4591,163,167Nov 14 04:05 PM
ACKERMAN JOELCFO and TreasuerSep 16 '24Option Exercise75.9578,9995,999,974185,740Sep 17 06:08 PM
Rodriguez JavierChief Executive OfficerSep 16 '24Sale165.0550,0008,252,515837,835Sep 17 06:07 PM
Rodriguez JavierChief Executive OfficerSep 13 '24Sale162.859,8811,609,122887,835Sep 17 06:07 PM
Javier RodriguezOfficerSep 16 '24Proposed Sale165.0550,0008,252,514Sep 16 05:47 PM
Michael StaffieriOfficerSep 16 '24Proposed Sale132.4137,2954,938,300Sep 16 05:47 PM
Waters Kathleen AlyceChief Legal & Pub. Affairs OffAug 28 '24Option Exercise75.9526,3331,999,991109,344Aug 29 06:21 PM
ACKERMAN JOELCFO and TreasuerAug 27 '24Sale155.0664,0299,928,586111,481Aug 29 06:13 PM
ACKERMAN JOELCFO and TreasuerAug 28 '24Sale155.024,740734,785106,741Aug 29 06:13 PM
Rodriguez JavierChief Executive OfficerAug 26 '24Sale155.9332,1765,017,303905,659Aug 28 05:36 PM
Rodriguez JavierChief Executive OfficerAug 27 '24Sale155.937,9431,238,589897,716Aug 28 05:36 PM
Joel AckermanOfficerAug 27 '24Proposed Sale155.0073,64711,415,285Aug 27 04:21 PM
Javier RodriguezOfficerAug 26 '24Proposed Sale155.9350,0007,796,500Aug 26 05:34 PM
NEHRA JOHN Mformer board member Aug 26 '24Proposed Sale153.9030,0004,616,967Aug 26 03:42 PM
Rodriguez JavierChief Executive OfficerAug 20 '24Option Exercise67.80750,00050,850,0001,453,929Aug 22 05:38 PM
STAFFIERI MICHAEL DAVIDChief Operating Officer, DKCAug 16 '24Sale150.1732,5804,892,382209,365Aug 19 06:35 PM
STAFFIERI MICHAEL DAVIDChief Operating Officer, DKCAug 15 '24Sale150.039,5391,431,126241,945Aug 19 06:35 PM
Waters Kathleen AlyceChief Legal & Pub. Affairs OffAug 13 '24Sale146.217,8571,148,76683,011Aug 15 06:05 PM
Michael StaffieriOfficerAug 15 '24Proposed Sale150.0142,1196,318,271Aug 15 04:16 PM
Kathleen WatersOfficerAug 13 '24Proposed Sale146.207,8571,148,724Aug 13 04:10 PM